Showing results (11-20 of 129) with videos related to
Sort By:
Pageof 13
Blood|February 8, 2007
p53 status dictates responses of B lymphomas to monotherapy with proteasome inhibitorsDuonan Yu, Martin Carroll, Andrei Thomas-TikhonenkoBlood|September 10, 2005
mTOR regulates cell survival after etoposide treatment in primary AML cellsQing Xu, James E Thompson, Martin CarrollThe Journal of Community and Supportive Oncology|April 9, 2016
Acute promyelocytic leukemia presenting as a paraspinal massNirav N Shah, Mark Stonecypher, Pallavi Gopal, et al.Blood|February 28, 2002
TEL/platelet-derived growth factor receptor beta activates phosphatidylinositol 3 (PI3) kinase and requires PI3 kinase to regulate the cell cycleJamil Dierov, Qing Xu, Raia Dierova, et al.Seminars in Hematology|November 14, 2024
A line in shifting sand: Can we define and target TP53 mutated MDS?Sarah Skuli, Andrew Matthews, Martin Carroll, et al.Expert Review of Proteomics|September 25, 2015
Progress in epigenetic histone modification analysis by mass spectrometry for clinical investigationsÖzlem Önder, Simone Sidoli, Martin Carroll, et al.Cancer Biology & Therapy|January 6, 2007
Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexaroteneDonald E Tsai, Selina M Luger, Allison Kemner, et al.Cancer Cell|September 13, 2011
Short hairpin RNA screen reveals bromodomain proteins as novel targets in acute myeloid leukemiaGerd A Blobel, Anna Kalota, Patricia V Sanchez, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Intrinsic resistance to JAK2 inhibition in myelofibrosisAnna Kalota, Grace R Jeschke, Martin Carroll, et al.Plos One|April 28, 2015
Eltrombopag modulates reactive oxygen species and decreases acute myeloid leukemia cell survivalAnna Kalota, Mary A Selak, Laura A Garcia-Cid, et al.Pageof 13